Kano Kiyoshi, Kuwayama Yasuaki
Department of Ophthalmology, Osaka Koseinenkin Hospital, 4-2-78 Fukushima, Fukushima-ku, Osaka 553-0003, Japan.
Nippon Ganka Gakkai Zasshi. 2003 Jul;107(7):375-9.
Measurement of diurnal variation of intraocular pressure(IOP) is important for precise diagnosis of normal-tension glaucoma(NTG). We studied diurnal variation of IOP of NTG using a self-measuring tonometer.
A total of 159 patients(318 eyes) who were diagnosed as having NTG in Osaka Koseinenkin Hospital between 1994 and 2002 measured their own diurnal variation of IOP at home every 3 hours (8 times a day) using a prototype self-measuring non-contact air-puff tonometer(Hometonometer).
The maximum IOP, the minimum IOP, and the range of diurnal variation of IOP were 16.8 +/- 2.0 mmHg(mean +/- standard deviation), 12.8 +/- 1.7 mmHg, and 4.0 +/- 1.3 mmHg, respectively. Maximum IOP occurred most frequently at noon(24.3%), 9:00 am(21.4%), and 6:00 am(17.4%). In 69.2% of eyes, maximum IOP was found during outpatient clinic hours(9:00 am to 6:00 pm). Minimum IOP occurred most frequently at midnight(34.1%), 3:00 am(22.8%), and 9:00 pm(17.8%).
Approximately 30% of NTG patients have maximum IOP outside of outpatient clinic hours, and therefore measuring IOP in the early morning is important for determining the precise diurnal variation of their IOP. We hope that a safe self-measuring tonometer with which patients can measure their own IOP will be come commercially available soon, so that we can provide them with more individualized glaucoma treatment using the appropriate combination of medicines.
眼压(IOP)昼夜变化的测量对于正常眼压性青光眼(NTG)的精确诊断很重要。我们使用一种自测量眼压计研究了NTG患者的眼压昼夜变化。
1994年至2002年间在大阪厚生年金医院被诊断为NTG的159例患者(318只眼),使用原型自测量非接触式气吹眼压计(家用眼压计)在家中每3小时(每天8次)测量自己的眼压昼夜变化。
眼压的最大值、最小值和昼夜变化范围分别为16.8±2.0 mmHg(平均值±标准差)、12.8±1.7 mmHg和4.0±1.3 mmHg。眼压最大值最常出现在中午(24.3%)、上午9:00(21.4%)和上午6:00(17.4%)。在69.2%的眼中,眼压最大值出现在门诊时间(上午9:00至下午6:00)。眼压最小值最常出现在午夜(34.1%)、凌晨3:00(22.8%)和晚上9:00(17.8%)。
约30%的NTG患者眼压最大值出现在门诊时间之外,因此清晨测量眼压对于确定其眼压的精确昼夜变化很重要。我们希望一种患者可以自行测量眼压的安全自测量眼压计能尽快上市,以便我们能够通过适当的药物组合为他们提供更个性化的青光眼治疗。